Concord Healthcare (HKG:2453) agreed to place 48.72 million new H shares at HK$5.54 each to no fewer than six institutional or professional investors to raise net proceeds of about HK$258.8 million, according to a Tuesday filing.
The placing price represents a 16.9% discount to the company's last closing price on July 21 and a 19.9% discount to the five-day average closing price.
The new shares represent about 18.38% of Concord's issued H shares and 6.63% of its total issued share capital before the placement.
Proceeds will be used to fund the construction of a Shanghai cancer hospital, support medical AI operations, repay financial institution loans, and supplement general working capital, the filing said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.